Remove 0BACAE28-5315-4707-A71D-1FA05C2B0B64-4.EXE malware
0BACAE28-5315-4707-A71D-1FA05C2B0B64-4.EXE Malware Removal Guide
Manual removal instructions:
Antivirus Report of 0BACAE28-5315-4707-A71D-1FA05C2B0B64-4.EXE:
0bacae28-5315-4707-a71d-1fa05c2b0b64-4.exe
We suggest you to remove 0BACAE28-5315-4707-A71D-1FA05C2B0B64-4.EXE from your computer as soon as possible.
0BACAE28-5315-4707-A71D-1FA05C2B0B64-4.EXE is known as: Cinemaxversion3.0 exe
Antivirus testing: 21 / 68
Dangerous Status: Adware
Malware Aliases: PUP/Win32.CrossRider Adware/CrossRider.ZZ Generic PUA.Win32.CrossRider Trojan.Crossrider1.9517.
MD5 of 0BACAE28-5315-4707-A71D-1FA05C2B0B64-4.EXE = 8037EC90B02AC68B1518BE99B80BC648
0BACAE28-5315-4707-A71D-1FA05C2B0B64-4.EXE size is 1477608 bytes.
Full path on a computer: C:\PROGRAM FILES\CINEMAXVERSION3.0\0BACAE28-5315-4707-A71D-1FA05C2B0B64-4.EXE
0BACAE28-5315-4707-A71D-1FA05C2B0B64-4.EXE | Cinemaxversion3.0 exe Antivirus testing: 21 / 68 Dangerous Status: Adware Malware Aliases: PUP/Win32.CrossRider Adware/CrossRider.ZZ Generic PUA.Win32.CrossRider Trojan.Crossrider1.9517. |
0BACAE28-5315-4707-A71D-1FA05C2B0B64-4.EXE | Dangerous |
0BACAE28-5315-4707-A71D-1FA05C2B0B64-4.EXE | High Risk |
0BACAE28-5315-4707-A71D-1FA05C2B0B64-4.EXE is known as: Cinemaxversion3.0 exe
Antivirus testing: 21 / 68
Dangerous Status: Adware
Malware Aliases: PUP/Win32.CrossRider Adware/CrossRider.ZZ Generic PUA.Win32.CrossRider Trojan.Crossrider1.9517.
MD5 of 0BACAE28-5315-4707-A71D-1FA05C2B0B64-4.EXE = 8037EC90B02AC68B1518BE99B80BC648
0BACAE28-5315-4707-A71D-1FA05C2B0B64-4.EXE size is 1477608 bytes.
Full path on a computer: C:\PROGRAM FILES\CINEMAXVERSION3.0\0BACAE28-5315-4707-A71D-1FA05C2B0B64-4.EXE
Dmitry Sokolov:
I created UnHackMe in 2006 to fix the problem that antivioruses did not fix: detecting rootkits.
Since that time I work every day to fix the issues that antiviruses cannot.
If your antivirus have not helped you solve the problem, you should try UnHackMe.
We are a small company and you can ask me directly, if you have any questions.